QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer
Completed · Phase 2 · Has a placebo group
Conditions studied: Breast Cancer, Breast Tumors, Metastatic Cancer
In brief
This is a randomized, double-blind, placebo-controlled, phase 2 study. Subjects will include postmenopausal women with confirmed HR-positive, locally advanced or metastatic breast cancer, who have disease progression during or within 12 months after completing prior adjuvant endocrine therapy or during the first prior endocrine therapy for metastatic disease.
Key facts
- Study ID
- NCT00626106
- Run by
- NantCell, Inc.
- People needed
- 156
- Starts
- 2008-03-27
- Expected to finish
- 2011-09-23
- Last updated by the study team
- 2024-09-19
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Histologically or cytologically confirmed carcinoma of the breast with locally advanced or metastatic disease
- Confirmation of hormone receptor (HR) positive disease status
- Amenable to receive endocrine therapy
- Disease progression while receiving prior endocrine therapy for locally advanced or metastatic breast cancer
- Postmenopausal woman ≥ 18 years old
You may not qualify if…
- HR-unknown or HR-negative disease
- Not amenable to endocrine therapy
- Central nervous system metastasis
Where it is running
- Research Site — Anaheim, California, United States
- Research Site — Beverly Hills, California, United States
- Research Site — Concord, California, United States
- Research Site — Duarte, California, United States
- Research Site — Montebello, California, United States
- Research Site — San Francisco, California, United States
- Research Site — Sylmar, California, United States
- Research Site — Stamford, Connecticut, United States
- Research Site — Boca Raton, Florida, United States
- Research Site — Boynton Beach, Florida, United States
- Research Site — Coral Springs, Florida, United States
- Research Site — Gainesville, Florida, United States
- Research Site — Lake Worth, Florida, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Marietta, Georgia, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Lebanon, New Hampshire, United States
- Research Site — Denville, New Jersey, United States
- Research Site — High Point, North Carolina, United States
- Research Site — Hershey, Pennsylvania, United States
- Research Site — Pittsburgh, Pennsylvania, United States
- Research Site — Memphis, Tennessee, United States
- Research Site — American Fork, Utah, United States
- Research Site — Tacoma, Washington, United States
- Research Site — Chandler, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.